Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH¿AEG¿SEPD¿SEOM¿GETECCU Mar Riveiro-Barciela; Sabela Carballal; Álvaro Díaz-González; Míriam Mañosa; Javier Gallego-Plazas; Joaquín Cubiella; Paula Jiménez-Fonseca; María Varela; Luis Menchén; Bruno Sangro; Ana Fernández-Montes; Francisco Mesonero; Miguel Ángel Rodríguez-Gandía; Fernando Rivera; María-Carlota Londoño;

Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases Henrique C. Rocha; Eduardo G. Vilela;

Corticosteroids in inflammatory bowel disease: Are they still a therapeutic option? Rodrigo Quera; Paulina Núñez; Beatriz Sicilia; Lilian Flores; Fernando Gomollón;